| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6033159 | NeuroImage | 2012 | 5 Pages |
Abstract
⺠In serotoninergic areas [18F]FDOPA uptake reflects serotonin transporter availability. ⺠[18F]FDOPA PET is a valid marker of serotoninergic function in Parkinson disease. ⺠Support previous studies of serotonin function in Parkinsonism with [18F]FDOPA PET.
Related Topics
Life Sciences
Neuroscience
Cognitive Neuroscience
Authors
N. Pavese, B.S. Simpson, V. Metta, A. Ramlackhansingh, K. Ray Chaudhuri, D.J. Brooks,
![First Page Preview: [18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease [18F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [18F]FDOPA and [11C]DASB PET study in Parkinson's disease](/preview/png/6033159.png)